Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02972853 · ClinicalTrials.gov registry record · NA

Mindful Self-Regulation fMRI Pilot Study

A NA study, sponsored by Cambridge Health Alliance.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT02972853: Completed NA study, sponsored by Cambridge Health Alliance.

NCT02972853 is a NA study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02972853, a NA study, has completed, sponsored by Cambridge Health Alliance.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to 1) determine whether Mindfulness Training for Primary Care (see study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study") engages self-regulation targets such as emotion regulation, attention, and interoceptive awareness; and 2) changes brain activation in neuroimaging tasks before compared to after the training. Neuroimaging fMRI tasks probe mechanisms related to self-regulation, such as attention/inhibition, emotion regulation, self-compassion, interoception and pain regulation. The study will also look at whether chronic disease self-management and successful engagement of self-report and behavioral self-regulation targets (emotion regulation, attention, and interoceptive awareness) relates to the observed brain activation changes after compared to before the mindfulness intervention.

Primary Outcome

Change in brain activation will be measured with functional magnetic resonance imaging (fMRI) during four different tasks: an affective go/nogo regulation task, an interoceptive attention task, a self-compassion task and a pain regulation task. Brain activation will be compared between baseline and Week 8.

Interventions

  • BEHAVIORAL Mindfulness Training for Primary Care (MTPC)

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2016-09
Est. Completion 2020-10
Phase NA
Cambridge Health Alliance

45 total trials

What the finished NCT02972853 record still lists

NCT02972853 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness Training for Primary Care (MTPC) is the first listed.

NCT02972853 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02972853 about?

NCT02972853 is a clinical study titled "Mindful Self-Regulation fMRI Pilot Study". The purpose of this study is to 1) determine whether Mindfulness Training for Primary Care (see study "MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home - A Pilot Study") engages self-regulation targets such as emotion regulation, attention, and interoceptive awareness; and ...

What is the current status of trial NCT02972853?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2016-09. Estimated completion is 2020-10.

What interventions are being tested in trial NCT02972853?

The interventions under investigation include: Mindfulness Training for Primary Care (MTPC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02972853?

This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02972853's enrollment target sits among peer trials

26 1710th of 2000 higher than 289 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02972853, the US trial registry maintained by the National Library of Medicine. NCT02972853 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.